drugset / Trial / NCT02096133

Vitamin D3 and the Stress-axis in MS

NCT02096133

Phase 2 Terminated 54 enrolled Academic MS Center Limburg
RandomizedParallel-groupQuadruple-blindOther

Summary

Patients with multiple sclerosis (MS) have an increased risk of developing a major depression. The investigators observed a protective effect of high vitamin D levels on the risk of depression in MS. This might be driven by the effect of vitamin D on the stress-axis. Therefore, the main goal of the present study is to assess whether high dose vitamin D supplementation results in a suppression of the stress-axis, as measured by decreased levels of cortisol.

Timeline

Start
2014-10-13
Primary completion
2016-11-07
Completion
2016-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 100 ug

Indications